The uptake of bleomycin (BLM) by various types of brain tumours after intravenous or intrathecal administration was investigated by bioassay in 67 patients. The correlation between the BLM distribution and the type and characteristics of brain tumours was studied.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
↵2 Address for reprint requests: Dr Toru Hayakawa, Department of Neurosurgery, Osaka University Hospital, 3-Dojima-hamadori, Fukushima-ku, Osaka, Japan.
↵1 This work was supported in part by grants-in-aid for Fundamental Scientific Research from the Ministry of Public Welfare and from the Ministry of Education.